BECTON DICKINSON & CO (BDX)
BECTON DICKINSON & CO (BDX) from its SEC filings: 2025 revenue $21.8 billion (+8% vs the year before), net margin 8%. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $21.8 billion |
| Revenue growth | +8% |
| Net income | $1.7 billion |
| Net margin | 7.7% |
| Diluted EPS | $5.82 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +5% |
| Cash | $708.0 million |
| Long-term debt | $13.5 billion |
| Share count, 1 year | -5% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.